Volitionrx Stock Revenue
| VNRX Stock | USD 0.69 0.01 1.43% |
Volitionrx fundamentals help investors to digest information that contributes to Volitionrx's financial success or failures. It also enables traders to predict the movement of Volitionrx Stock. The fundamental analysis module provides a way to measure Volitionrx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Volitionrx stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 775.3 K | 814.1 K |
Volitionrx | Revenue |
Volitionrx Company Revenue Analysis
Volitionrx's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Volitionrx Revenue | 775.3 K |
Most of Volitionrx's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Volitionrx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Volitionrx
Projected quarterly revenue analysis of Volitionrx provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Volitionrx match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Volitionrx's stock price.
Volitionrx Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Volitionrx is extremely important. It helps to project a fair market value of Volitionrx Stock properly, considering its historical fundamentals such as Revenue. Since Volitionrx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Volitionrx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Volitionrx's interrelated accounts and indicators.
| -0.05 | 0.99 | -0.3 | 0.84 | 0.47 | ||
| -0.05 | -0.02 | -0.16 | 0.18 | 0.36 | ||
| 0.99 | -0.02 | -0.33 | 0.87 | 0.51 | ||
| -0.3 | -0.16 | -0.33 | -0.51 | -0.84 | ||
| 0.84 | 0.18 | 0.87 | -0.51 | 0.77 | ||
| 0.47 | 0.36 | 0.51 | -0.84 | 0.77 |
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Volitionrx Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Volitionrx reported 775.3 K of revenue. This is 99.99% lower than that of the Health Care Equipment & Supplies sector and 99.96% lower than that of the Health Care industry. The revenue for all United States stocks is 99.99% higher than that of the company.
Volitionrx Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Volitionrx's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Volitionrx could also be used in its relative valuation, which is a method of valuing Volitionrx by comparing valuation metrics of similar companies.Volitionrx is currently under evaluation in revenue category among its peers.
Volitionrx Current Valuation Drivers
We derive many important indicators used in calculating different scores of Volitionrx from analyzing Volitionrx's financial statements. These drivers represent accounts that assess Volitionrx's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Volitionrx's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 185.7M | 176.1M | 165.3M | 134.5M | 51.1M | 75.8M | |
| Enterprise Value | 172.7M | 161.1M | 148.8M | 128.6M | 36.2M | 68.4M |
Volitionrx Fundamentals
| Return On Equity | -7.3 | ||||
| Return On Asset | -1.01 | ||||
| Operating Margin | (17.66) % | ||||
| Current Valuation | 64.86 M | ||||
| Shares Outstanding | 92.66 M | ||||
| Shares Owned By Insiders | 22.80 % | ||||
| Shares Owned By Institutions | 19.10 % | ||||
| Number Of Shares Shorted | 441.92 K | ||||
| Price To Earning | (4.52) X | ||||
| Price To Book | 38.44 X | ||||
| Price To Sales | 66.12 X | ||||
| Revenue | 775.3 K | ||||
| Gross Profit | 306.39 K | ||||
| EBITDA | (34.04 M) | ||||
| Net Income | (35.32 M) | ||||
| Cash And Equivalents | 16.42 M | ||||
| Cash Per Share | 0.28 X | ||||
| Total Debt | 5.86 M | ||||
| Debt To Equity | 1.57 % | ||||
| Current Ratio | 1.04 X | ||||
| Book Value Per Share | (0.1) X | ||||
| Cash Flow From Operations | (18.06 M) | ||||
| Short Ratio | 3.71 X | ||||
| Earnings Per Share | (0.36) X | ||||
| Target Price | 3.28 | ||||
| Number Of Employees | 101 | ||||
| Beta | 1.1 | ||||
| Market Capitalization | 64.57 M | ||||
| Total Asset | 27.95 M | ||||
| Retained Earnings | (202.58 M) | ||||
| Working Capital | (9.98 M) | ||||
| Current Asset | 6.22 M | ||||
| Current Liabilities | 1.12 M | ||||
| Net Asset | 27.95 M |
About Volitionrx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Volitionrx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Volitionrx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Volitionrx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Volitionrx Stock Analysis
When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.